P

Porton Pharma Solutions Ltd
SZSE:300363

Watchlist Manager
Porton Pharma Solutions Ltd
SZSE:300363
Watchlist
Price: 17.33 CNY 2.24% Market Closed
Market Cap: 9.5B CNY
Have any thoughts about
Porton Pharma Solutions Ltd?
Write Note

Porton Pharma Solutions Ltd
Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Porton Pharma Solutions Ltd
Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
P
Porton Pharma Solutions Ltd
SZSE:300363
Minority Interest
ÂĄ254.4m
CAGR 3-Years
1%
CAGR 5-Years
380%
CAGR 10-Years
15%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Minority Interest
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Minority Interest
ÂĄ575.3m
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Minority Interest
ÂĄ564.9m
CAGR 3-Years
-1%
CAGR 5-Years
41%
CAGR 10-Years
5%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Minority Interest
ÂĄ20.9m
CAGR 3-Years
-54%
CAGR 5-Years
-32%
CAGR 10-Years
-16%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Porton Pharma Solutions Ltd
Glance View

Market Cap
9.5B CNY
Industry
Pharmaceuticals

Porton Pharma Solutions Ltd. engages in the research and development and manufacture of pharmaceutical products and active pharmaceutical ingredients. The company is headquartered in Chongqing, Chongqing and currently employs 3,782 full-time employees. The company went IPO on 2014-01-29. The firm is also engaged in the multi-client product manufacturing businesses and pharmaceutical and chemical commerce businesses. The products of the Company include anti-viral, anti-diabetic, hypolipidemic, anti-cancer, anesthesia analgesia and anti-bacterial pharmaceuticals, among others. The firm operates its businesses in Europe, North America, Asia and China, among others.

Intrinsic Value
20.26 CNY
Undervaluation 14%
Intrinsic Value
Price
P

See Also

What is Porton Pharma Solutions Ltd's Minority Interest?
Minority Interest
254.4m CNY

Based on the financial report for Sep 30, 2024, Porton Pharma Solutions Ltd's Minority Interest amounts to 254.4m CNY.

What is Porton Pharma Solutions Ltd's Minority Interest growth rate?
Minority Interest CAGR 10Y
15%

Over the last year, the Minority Interest growth was -15%. The average annual Minority Interest growth rates for Porton Pharma Solutions Ltd have been 1% over the past three years , 380% over the past five years , and 15% over the past ten years .

Back to Top